Eric S Rosenthal, MD

Dr. Rosenthal is associate professor of neurology at Harvard Medical School. Board certified in neurology, epilepsy, and neurocritical care, he serves as Medical Director of the Neurosciences Intensive Care Unit at Massachusetts General Hospital.

He is also a core faculty member of the Mass General Brigham Center for Neurotechnology and NeuroRecovery (CNTR) and directory of the Mass General Brigham NeuroAI Center. At the state and national level, he has served on the Massachusetts Governor's Strategic AI Task Force and as co-chair for the NIH Bridge to Artificial Intelligence Consortium's Steering Committee. 1) infrastructure to enable collaborative data science, quality improvement, and trustworthy AI, 2) development and validation of neurophysiologic biomarkers, measurement of quality measures, and 3) the use of neuromonitoring to design innovative clinical trials. He is the Contact PI for the Bridge2AI CHoRUS for Clinical Care program, Co-PI of the ELECTRO-BOOST study of EEG in Traumatic Brain Injury, and the Co-PI of the upcoming Ketamine for Established Status Epilepticus Study (KESETT), and a site PI within the TRACK-TBI and SIREN networks.

Dr. Rosenthal graduated from Harvard Medical School. He completed his residency at the Harvard/Mass General Brigham Neurology Residency Training Program, and completed fellowship training within the MGH/BWH/Harvard Neurocritical Care Fellowship Training Program, the MGH Epilepsy Fellowship program and the MGH Clinical Neurophysiology Fellowship program.